Rhodia announces the divestment project to Novacap for its salicylic and acetami
Rhodia announces the divestment project to Novacap for its salicylic and acetaminophen activities. Salicylates, which are used as active ingredients in the pharmaceutical industry (aspirin, acetaminophen) or as synthesis intermediates (salicylic acid


















